The DRIP Study: desensitisation of highly pre-sensitised dialysis patients waiting for kidney transplantation by Rituximab, Intravenous Immunoglobulin-L (IVIG-L) and rescue Plasmapheresis (AMC-DRIP)

Update Il y a 5 ans
Reference: ISRCTN76326553

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Not provided at time of registration


Inclusion criteria

  • Highly sensitised renal transplant recipients

Links